ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global HIV-1 ELISA Kits Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-30M16610
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global HIV 1 ELISA Kits Market Research Report 2024
BUY CHAPTERS

Global HIV-1 ELISA Kits Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-30M16610
Report
November 2025
Pages:153
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
MyBioSource
XpressBio
R&D Systems
RayBiotech
Abbexa
Sino Biological
Novus Biologicals
Abnova Corporation
Origene Technologies
United States Biological
Wuhan Fine Biotech
ACROBiosystems
Krishgen Biosystems
R&D Systems

HIV-1 ELISA Kits Market

The global HIV-1 ELISA Kits market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
HIV-1 ELISA kits are enzyme-linked immunosorbent assay kits designed for the detection and quantification of antibodies specific to Human Immunodeficiency Virus type 1 (HIV-1) in biological samples. These kits use the ELISA method to detect the presence of antibodies produced by the immune system in response to HIV-1 infection. HIV-1 ELISA kits are integral in diagnosing HIV infections, monitoring disease progression, and screening blood donations for HIV. They provide a sensitive and specific tool for detecting antibodies against HIV-1, aiding in the early detection and management of the virus in clinical settings.
The industry trend for HIV-1 ELISA kits is evolving in response to the global HIV epidemic and the need for accurate diagnostic tools. With a focus on early detection and treatment of HIV infections to mitigate transmission and improve patient outcomes, there is a growing demand for reliable and high-quality ELISA kits for HIV-1. Manufacturers are constantly innovating to improve the sensitivity, specificity, and accessibility of these kits, making them essential in healthcare settings worldwide. As diagnostic testing plays a pivotal role in HIV management and prevention strategies, the market for HIV-1 ELISA kits is expected to continue growing.

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global HIV-1 ELISA Kits market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of HIV-1 ELISA Kits Market Report

Report Metric Details
Report Name HIV-1 ELISA Kits Market
Segment by Type
  • Anti-HIV-1
  • HIV-1
Segment by Application
  • Hospital
  • Laboratory
  • Others
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company MyBioSource, XpressBio, R&D Systems, RayBiotech, Abbexa, Sino Biological, Novus Biologicals, Abnova Corporation, OriGene Technologies, United States Biological, Wuhan Fine Biotech, ACROBiosystems, Krishgen Biosystems
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the HIV-1 ELISA Kits study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the HIV-1 ELISA Kits Market report?

Ans: The main players in the HIV-1 ELISA Kits Market are MyBioSource, XpressBio, R&D Systems, RayBiotech, Abbexa, Sino Biological, Novus Biologicals, Abnova Corporation, OriGene Technologies, United States Biological, Wuhan Fine Biotech, ACROBiosystems, Krishgen Biosystems

What are the Application segmentation covered in the HIV-1 ELISA Kits Market report?

Ans: The Applications covered in the HIV-1 ELISA Kits Market report are Hospital, Laboratory, Others

What are the Type segmentation covered in the HIV-1 ELISA Kits Market report?

Ans: The Types covered in the HIV-1 ELISA Kits Market report are Anti-HIV-1, HIV-1

1 Study Coverage
1.1 Introduction to HIV-1 ELISA Kits: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global HIV-1 ELISA Kits Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Anti-HIV-1
1.2.3 HIV-1
1.3 Market Segmentation by Application
1.3.1 Global HIV-1 ELISA Kits Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Laboratory
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global HIV-1 ELISA Kits Revenue Estimates and Forecasts 2020-2031
2.2 Global HIV-1 ELISA Kits Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global HIV-1 ELISA Kits Sales Estimates and Forecasts 2020-2031
2.4 Global HIV-1 ELISA Kits Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global HIV-1 ELISA Kits Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global HIV-1 ELISA Kits Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Anti-HIV-1 Market Size by Manufacturers
3.5.2 HIV-1 Market Size by Manufacturers
3.6 Global HIV-1 ELISA Kits Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global HIV-1 ELISA Kits Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global HIV-1 ELISA Kits Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global HIV-1 ELISA Kits Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global HIV-1 ELISA Kits Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America HIV-1 ELISA Kits Sales and Revenue by Type (2020-2031)
6.4 North America HIV-1 ELISA Kits Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America HIV-1 ELISA Kits Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe HIV-1 ELISA Kits Sales and Revenue by Type (2020-2031)
7.4 Europe HIV-1 ELISA Kits Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe HIV-1 ELISA Kits Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific HIV-1 ELISA Kits Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific HIV-1 ELISA Kits Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific HIV-1 ELISA Kits Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America HIV-1 ELISA Kits Sales and Revenue by Type (2020-2031)
9.4 Central and South America HIV-1 ELISA Kits Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America HIV-1 ELISA Kits Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa HIV-1 ELISA Kits Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa HIV-1 ELISA Kits Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa HIV-1 ELISA Kits Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 MyBioSource
11.1.1 MyBioSource Corporation Information
11.1.2 MyBioSource Business Overview
11.1.3 MyBioSource HIV-1 ELISA Kits Product Models, Descriptions and Specifications
11.1.4 MyBioSource HIV-1 ELISA Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 MyBioSource HIV-1 ELISA Kits Sales by Product in 2024
11.1.6 MyBioSource HIV-1 ELISA Kits Sales by Application in 2024
11.1.7 MyBioSource HIV-1 ELISA Kits Sales by Geographic Area in 2024
11.1.8 MyBioSource HIV-1 ELISA Kits SWOT Analysis
11.1.9 MyBioSource Recent Developments
11.2 XpressBio
11.2.1 XpressBio Corporation Information
11.2.2 XpressBio Business Overview
11.2.3 XpressBio HIV-1 ELISA Kits Product Models, Descriptions and Specifications
11.2.4 XpressBio HIV-1 ELISA Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 XpressBio HIV-1 ELISA Kits Sales by Product in 2024
11.2.6 XpressBio HIV-1 ELISA Kits Sales by Application in 2024
11.2.7 XpressBio HIV-1 ELISA Kits Sales by Geographic Area in 2024
11.2.8 XpressBio HIV-1 ELISA Kits SWOT Analysis
11.2.9 XpressBio Recent Developments
11.3 R&D Systems
11.3.1 R&D Systems Corporation Information
11.3.2 R&D Systems Business Overview
11.3.3 R&D Systems HIV-1 ELISA Kits Product Models, Descriptions and Specifications
11.3.4 R&D Systems HIV-1 ELISA Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 R&D Systems HIV-1 ELISA Kits Sales by Product in 2024
11.3.6 R&D Systems HIV-1 ELISA Kits Sales by Application in 2024
11.3.7 R&D Systems HIV-1 ELISA Kits Sales by Geographic Area in 2024
11.3.8 R&D Systems HIV-1 ELISA Kits SWOT Analysis
11.3.9 R&D Systems Recent Developments
11.4 RayBiotech
11.4.1 RayBiotech Corporation Information
11.4.2 RayBiotech Business Overview
11.4.3 RayBiotech HIV-1 ELISA Kits Product Models, Descriptions and Specifications
11.4.4 RayBiotech HIV-1 ELISA Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 RayBiotech HIV-1 ELISA Kits Sales by Product in 2024
11.4.6 RayBiotech HIV-1 ELISA Kits Sales by Application in 2024
11.4.7 RayBiotech HIV-1 ELISA Kits Sales by Geographic Area in 2024
11.4.8 RayBiotech HIV-1 ELISA Kits SWOT Analysis
11.4.9 RayBiotech Recent Developments
11.5 Abbexa
11.5.1 Abbexa Corporation Information
11.5.2 Abbexa Business Overview
11.5.3 Abbexa HIV-1 ELISA Kits Product Models, Descriptions and Specifications
11.5.4 Abbexa HIV-1 ELISA Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Abbexa HIV-1 ELISA Kits Sales by Product in 2024
11.5.6 Abbexa HIV-1 ELISA Kits Sales by Application in 2024
11.5.7 Abbexa HIV-1 ELISA Kits Sales by Geographic Area in 2024
11.5.8 Abbexa HIV-1 ELISA Kits SWOT Analysis
11.5.9 Abbexa Recent Developments
11.6 Sino Biological
11.6.1 Sino Biological Corporation Information
11.6.2 Sino Biological Business Overview
11.6.3 Sino Biological HIV-1 ELISA Kits Product Models, Descriptions and Specifications
11.6.4 Sino Biological HIV-1 ELISA Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Sino Biological Recent Developments
11.7 Novus Biologicals
11.7.1 Novus Biologicals Corporation Information
11.7.2 Novus Biologicals Business Overview
11.7.3 Novus Biologicals HIV-1 ELISA Kits Product Models, Descriptions and Specifications
11.7.4 Novus Biologicals HIV-1 ELISA Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Novus Biologicals Recent Developments
11.8 Abnova Corporation
11.8.1 Abnova Corporation Corporation Information
11.8.2 Abnova Corporation Business Overview
11.8.3 Abnova Corporation HIV-1 ELISA Kits Product Models, Descriptions and Specifications
11.8.4 Abnova Corporation HIV-1 ELISA Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Abnova Corporation Recent Developments
11.9 OriGene Technologies
11.9.1 OriGene Technologies Corporation Information
11.9.2 OriGene Technologies Business Overview
11.9.3 OriGene Technologies HIV-1 ELISA Kits Product Models, Descriptions and Specifications
11.9.4 OriGene Technologies HIV-1 ELISA Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 OriGene Technologies Recent Developments
11.10 United States Biological
11.10.1 United States Biological Corporation Information
11.10.2 United States Biological Business Overview
11.10.3 United States Biological HIV-1 ELISA Kits Product Models, Descriptions and Specifications
11.10.4 United States Biological HIV-1 ELISA Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 United States Biological Recent Developments
11.11 Wuhan Fine Biotech
11.11.1 Wuhan Fine Biotech Corporation Information
11.11.2 Wuhan Fine Biotech Business Overview
11.11.3 Wuhan Fine Biotech HIV-1 ELISA Kits Product Models, Descriptions and Specifications
11.11.4 Wuhan Fine Biotech HIV-1 ELISA Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 Wuhan Fine Biotech Recent Developments
11.12 ACROBiosystems
11.12.1 ACROBiosystems Corporation Information
11.12.2 ACROBiosystems Business Overview
11.12.3 ACROBiosystems HIV-1 ELISA Kits Product Models, Descriptions and Specifications
11.12.4 ACROBiosystems HIV-1 ELISA Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 ACROBiosystems Recent Developments
11.13 Krishgen Biosystems
11.13.1 Krishgen Biosystems Corporation Information
11.13.2 Krishgen Biosystems Business Overview
11.13.3 Krishgen Biosystems HIV-1 ELISA Kits Product Models, Descriptions and Specifications
11.13.4 Krishgen Biosystems HIV-1 ELISA Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.13.5 Krishgen Biosystems Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 HIV-1 ELISA Kits Industry Chain
12.2 HIV-1 ELISA Kits Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 HIV-1 ELISA Kits Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 HIV-1 ELISA Kits Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 HIV-1 ELISA Kits Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global HIV-1 ELISA Kits Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
FEATURED COMPANIES
MyBioSource
XpressBio
R&D Systems
RayBiotech
Abbexa
Sino Biological
Novus Biologicals
Abnova Corporation
Origene Technologies
United States Biological
Wuhan Fine Biotech
ACROBiosystems
Krishgen Biosystems
R&D Systems
List of Tables
 Table 1. Global HIV-1 ELISA Kits Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global HIV-1 ELISA Kits Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global HIV-1 ELISA Kits Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global HIV-1 ELISA Kits Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global HIV-1 ELISA Kits Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global HIV-1 ELISA Kits Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
 Table 7. Global HIV-1 ELISA Kits Sales by Region (2020-2025) & (K Units)
 Table 8. Global HIV-1 ELISA Kits Sales by Region (2026-2031) & (K Units)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global HIV-1 ELISA Kits Sales by Manufacturers (2020-2025) & (K Units)
 Table 11. Global HIV-1 ELISA Kits Sales Share by Manufacturers (2020-2025)
 Table 12. Global HIV-1 ELISA Kits Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 13. Global HIV-1 ELISA Kits Revenue Market Share by Manufacturers (2020-2025)
 Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 15. Global HIV-1 ELISA Kits by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HIV-1 ELISA Kits as of 2024)
 Table 16. Global HIV-1 ELISA Kits Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 17. Global HIV-1 ELISA Kits Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
 Table 18. Key Manufacturers HIV-1 ELISA Kits Manufacturing Base and Headquarters
 Table 19. Global HIV-1 ELISA Kits Market Concentration Ratio (CR5 and HHI)
 Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 22. Global HIV-1 ELISA Kits Sales by Type (2020-2025) & (K Units)
 Table 23. Global HIV-1 ELISA Kits Sales by Type (2026-2031) & (K Units)
 Table 24. Global HIV-1 ELISA Kits Revenue by Type (2020-2025) & (US$ Million)
 Table 25. Global HIV-1 ELISA Kits Revenue by Type (2026-2031) & (US$ Million)
 Table 26. Global HIV-1 ELISA Kits ASP by Type (2020-2031) & (US$/Unit)
 Table 27. Technical Specifications by Key Product Type
 Table 28. Global HIV-1 ELISA Kits Sales by Application (2020-2025) & (K Units)
 Table 29. Global HIV-1 ELISA Kits Sales by Application (2026-2031) & (K Units)
 Table 30. HIV-1 ELISA Kits High-Growth Sectors Demand CAGR (2024-2031)
 Table 31. Global HIV-1 ELISA Kits Revenue by Application (2020-2025) & (US$ Million)
 Table 32. Global HIV-1 ELISA Kits Revenue by Application (2026-2031) & (US$ Million)
 Table 33. Global HIV-1 ELISA Kits ASP by Application (2020-2031) & (US$/Unit)
 Table 34. Top Customers by Region
 Table 35. Top Customers by Application
 Table 36. North America HIV-1 ELISA Kits Growth Accelerators and Market Barriers
 Table 37. North America HIV-1 ELISA Kits Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 38. North America HIV-1 ELISA Kits Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 39. Europe HIV-1 ELISA Kits Growth Accelerators and Market Barriers
 Table 40. Europe HIV-1 ELISA Kits Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Europe HIV-1 ELISA Kits Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 42. Asia-Pacific HIV-1 ELISA Kits Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 43. Asia-Pacific HIV-1 ELISA Kits Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 44. Asia-Pacific HIV-1 ELISA Kits Growth Accelerators and Market Barriers
 Table 45. Southeast Asia HIV-1 ELISA Kits Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Central and South America HIV-1 ELISA Kits Investment Opportunities and Key Challenges
 Table 47. Central and South America HIV-1 ELISA Kits Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 48. Middle East and Africa HIV-1 ELISA Kits Investment Opportunities and Key Challenges
 Table 49. Middle East and Africa HIV-1 ELISA Kits Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 50. MyBioSource Corporation Information
 Table 51. MyBioSource Description and Major Businesses
 Table 52. MyBioSource Product Models, Descriptions and Specifications
 Table 53. MyBioSource Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 54. MyBioSource Sales Value Proportion by Product in 2024
 Table 55. MyBioSource Sales Value Proportion by Application in 2024
 Table 56. MyBioSource Sales Value Proportion by Geographic Area in 2024
 Table 57. MyBioSource HIV-1 ELISA Kits SWOT Analysis
 Table 58. MyBioSource Recent Developments
 Table 59. XpressBio Corporation Information
 Table 60. XpressBio Description and Major Businesses
 Table 61. XpressBio Product Models, Descriptions and Specifications
 Table 62. XpressBio Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 63. XpressBio Sales Value Proportion by Product in 2024
 Table 64. XpressBio Sales Value Proportion by Application in 2024
 Table 65. XpressBio Sales Value Proportion by Geographic Area in 2024
 Table 66. XpressBio HIV-1 ELISA Kits SWOT Analysis
 Table 67. XpressBio Recent Developments
 Table 68. R&D Systems Corporation Information
 Table 69. R&D Systems Description and Major Businesses
 Table 70. R&D Systems Product Models, Descriptions and Specifications
 Table 71. R&D Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 72. R&D Systems Sales Value Proportion by Product in 2024
 Table 73. R&D Systems Sales Value Proportion by Application in 2024
 Table 74. R&D Systems Sales Value Proportion by Geographic Area in 2024
 Table 75. R&D Systems HIV-1 ELISA Kits SWOT Analysis
 Table 76. R&D Systems Recent Developments
 Table 77. RayBiotech Corporation Information
 Table 78. RayBiotech Description and Major Businesses
 Table 79. RayBiotech Product Models, Descriptions and Specifications
 Table 80. RayBiotech Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 81. RayBiotech Sales Value Proportion by Product in 2024
 Table 82. RayBiotech Sales Value Proportion by Application in 2024
 Table 83. RayBiotech Sales Value Proportion by Geographic Area in 2024
 Table 84. RayBiotech HIV-1 ELISA Kits SWOT Analysis
 Table 85. RayBiotech Recent Developments
 Table 86. Abbexa Corporation Information
 Table 87. Abbexa Description and Major Businesses
 Table 88. Abbexa Product Models, Descriptions and Specifications
 Table 89. Abbexa Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 90. Abbexa Sales Value Proportion by Product in 2024
 Table 91. Abbexa Sales Value Proportion by Application in 2024
 Table 92. Abbexa Sales Value Proportion by Geographic Area in 2024
 Table 93. Abbexa HIV-1 ELISA Kits SWOT Analysis
 Table 94. Abbexa Recent Developments
 Table 95. Sino Biological Corporation Information
 Table 96. Sino Biological Description and Major Businesses
 Table 97. Sino Biological Product Models, Descriptions and Specifications
 Table 98. Sino Biological Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 99. Sino Biological Recent Developments
 Table 100. Novus Biologicals Corporation Information
 Table 101. Novus Biologicals Description and Major Businesses
 Table 102. Novus Biologicals Product Models, Descriptions and Specifications
 Table 103. Novus Biologicals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 104. Novus Biologicals Recent Developments
 Table 105. Abnova Corporation Corporation Information
 Table 106. Abnova Corporation Description and Major Businesses
 Table 107. Abnova Corporation Product Models, Descriptions and Specifications
 Table 108. Abnova Corporation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 109. Abnova Corporation Recent Developments
 Table 110. OriGene Technologies Corporation Information
 Table 111. OriGene Technologies Description and Major Businesses
 Table 112. OriGene Technologies Product Models, Descriptions and Specifications
 Table 113. OriGene Technologies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 114. OriGene Technologies Recent Developments
 Table 115. United States Biological Corporation Information
 Table 116. United States Biological Description and Major Businesses
 Table 117. United States Biological Product Models, Descriptions and Specifications
 Table 118. United States Biological Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 119. United States Biological Recent Developments
 Table 120. Wuhan Fine Biotech Corporation Information
 Table 121. Wuhan Fine Biotech Description and Major Businesses
 Table 122. Wuhan Fine Biotech Product Models, Descriptions and Specifications
 Table 123. Wuhan Fine Biotech Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 124. Wuhan Fine Biotech Recent Developments
 Table 125. ACROBiosystems Corporation Information
 Table 126. ACROBiosystems Description and Major Businesses
 Table 127. ACROBiosystems Product Models, Descriptions and Specifications
 Table 128. ACROBiosystems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 129. ACROBiosystems Recent Developments
 Table 130. Krishgen Biosystems Corporation Information
 Table 131. Krishgen Biosystems Description and Major Businesses
 Table 132. Krishgen Biosystems Product Models, Descriptions and Specifications
 Table 133. Krishgen Biosystems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 134. Krishgen Biosystems Recent Developments
 Table 135. Key Raw Materials Distribution
 Table 136. Raw Materials Key Suppliers
 Table 137. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 138. Milestones in Production Technology Evolution
 Table 139. Distributors List
 Table 140. Market Trends and Market Evolution
 Table 141. Market Drivers and Opportunities
 Table 142. Market Challenges, Risks, and Restraints
 Table 143. Research Programs/Design for This Report
 Table 144. Key Data Information from Secondary Sources
 Table 145. Key Data Information from Primary Sources


List of Figures
 Figure 1. HIV-1 ELISA Kits Product Picture
 Figure 2. Global HIV-1 ELISA Kits Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Anti-HIV-1 Product Picture
 Figure 4. HIV-1 Product Picture
 Figure 5. Global HIV-1 ELISA Kits Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 6. Hospital
 Figure 7. Laboratory
 Figure 8. Others
 Figure 9. HIV-1 ELISA Kits Report Years Considered
 Figure 10. Global HIV-1 ELISA Kits Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global HIV-1 ELISA Kits Revenue (2020-2031) & (US$ Million)
 Figure 12. Global HIV-1 ELISA Kits Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 13. Global HIV-1 ELISA Kits Revenue Market Share by Region (2020-2031)
 Figure 14. Global HIV-1 ELISA Kits Sales (2020-2031) & (K Units)
 Figure 15. Global HIV-1 ELISA Kits Sales (CAGR) by Region (2020-2031) (K Units)
 Figure 16. Global HIV-1 ELISA Kits Sales Market Share by Region (2020-2031)
 Figure 17. Top 5 and Top 10 Manufacturers HIV-1 ELISA Kits Sales Volume Market Share in 2024
 Figure 18. Global HIV-1 ELISA Kits Revenue Market Share Ranking (2024)
 Figure 19. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 20. Anti-HIV-1 Revenue Market Share by Manufacturer in 2024
 Figure 21. HIV-1 Revenue Market Share by Manufacturer in 2024
 Figure 22. Global HIV-1 ELISA Kits Sales Market Share by Type (2020-2031)
 Figure 23. Global HIV-1 ELISA Kits Revenue Market Share by Type (2020-2031)
 Figure 24. Global HIV-1 ELISA Kits Sales Market Share by Application (2020-2031)
 Figure 25. Global HIV-1 ELISA Kits Revenue Market Share by Application (2020-2031)
 Figure 26. North America HIV-1 ELISA Kits Sales YoY (2020-2031) & (K Units)
 Figure 27. North America HIV-1 ELISA Kits Revenue YoY (2020-2031) & (US$ Million)
 Figure 28. North America Top 5 Manufacturers HIV-1 ELISA Kits Sales Revenue (US$ Million) in 2024
 Figure 29. North America HIV-1 ELISA Kits Sales Volume (K Units) by Type (2020- 2031)
 Figure 30. North America HIV-1 ELISA Kits Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 31. North America HIV-1 ELISA Kits Sales Volume (K Units) by Application (2020-2031)
 Figure 32. North America HIV-1 ELISA Kits Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 33. US HIV-1 ELISA Kits Revenue (2020-2031) & (US$ Million)
 Figure 34. Canada HIV-1 ELISA Kits Revenue (2020-2031) & (US$ Million)
 Figure 35. Mexico HIV-1 ELISA Kits Revenue (2020-2031) & (US$ Million)
 Figure 36. Europe HIV-1 ELISA Kits Sales YoY (2020-2031) & (K Units)
 Figure 37. Europe HIV-1 ELISA Kits Revenue YoY (2020-2031) & (US$ Million)
 Figure 38. Europe Top 5 Manufacturers HIV-1 ELISA Kits Sales Revenue (US$ Million) in 2024
 Figure 39. Europe HIV-1 ELISA Kits Sales Volume (K Units) by Type (2020-2031)
 Figure 40. Europe HIV-1 ELISA Kits Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 41. Europe HIV-1 ELISA Kits Sales Volume (K Units) by Application (2020-2031)
 Figure 42. Europe HIV-1 ELISA Kits Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 43. Germany HIV-1 ELISA Kits Revenue (2020-2031) & (US$ Million)
 Figure 44. France HIV-1 ELISA Kits Revenue (2020-2031) & (US$ Million)
 Figure 45. U.K. HIV-1 ELISA Kits Revenue (2020-2031) & (US$ Million)
 Figure 46. Italy HIV-1 ELISA Kits Revenue (2020-2031) & (US$ Million)
 Figure 47. Russia HIV-1 ELISA Kits Revenue (2020-2031) & (US$ Million)
 Figure 48. Asia-Pacific HIV-1 ELISA Kits Sales YoY (2020-2031) & (K Units)
 Figure 49. Asia-Pacific HIV-1 ELISA Kits Revenue YoY (2020-2031) & (US$ Million)
 Figure 50. Asia-Pacific Top 8 Manufacturers HIV-1 ELISA Kits Sales Revenue (US$ Million) in 2024
 Figure 51. Asia-Pacific HIV-1 ELISA Kits Sales Volume (K Units) by Type (2020- 2031)
 Figure 52. Asia-Pacific HIV-1 ELISA Kits Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 53. Asia-Pacific HIV-1 ELISA Kits Sales Volume (K Units) by Application (2020-2031)
 Figure 54. Asia-Pacific HIV-1 ELISA Kits Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 55. Indonesia HIV-1 ELISA Kits Revenue (2020-2031) & (US$ Million)
 Figure 56. Japan HIV-1 ELISA Kits Revenue (2020-2031) & (US$ Million)
 Figure 57. South Korea HIV-1 ELISA Kits Revenue (2020-2031) & (US$ Million)
 Figure 58. China Taiwan HIV-1 ELISA Kits Revenue (2020-2031) & (US$ Million)
 Figure 59. India HIV-1 ELISA Kits Revenue (2020-2031) & (US$ Million)
 Figure 60. Central and South America HIV-1 ELISA Kits Sales YoY (2020-2031) & (K Units)
 Figure 61. Central and South America HIV-1 ELISA Kits Revenue YoY (2020-2031) & (US$ Million)
 Figure 62. Central and South America Top 5 Manufacturers HIV-1 ELISA Kits Sales Revenue (US$ Million) in 2024
 Figure 63. Central and South America HIV-1 ELISA Kits Sales Volume (K Units) by Type (2021-2031)
 Figure 64. Central and South America HIV-1 ELISA Kits Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 65. Central and South America HIV-1 ELISA Kits Sales Volume (K Units) by Application (2020-2031)
 Figure 66. Central and South America HIV-1 ELISA Kits Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 67. Brazil HIV-1 ELISA Kits Revenue (2020-2025) & (US$ Million)
 Figure 68. Argentina HIV-1 ELISA Kits Revenue (2020-2025) & (US$ Million)
 Figure 69. Middle East, and Africa HIV-1 ELISA Kits Sales YoY (2020-2031) & (K Units)
 Figure 70. Middle East and Africa HIV-1 ELISA Kits Revenue YoY (2020-2031) & (US$ Million)
 Figure 71. Middle East and Africa Top 5 Manufacturers HIV-1 ELISA Kits Sales Revenue (US$ Million) in 2024
 Figure 72. Middle East and Africa HIV-1 ELISA Kits Sales Volume (K Units) by Type (2021-2031)
 Figure 73. South America HIV-1 ELISA Kits Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 74. Middle East and Africa HIV-1 ELISA Kits Sales Volume (K Units) by Application (2020-2031)
 Figure 75. Middle East and Africa HIV-1 ELISA Kits Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 76. GCC Countries HIV-1 ELISA Kits Revenue (2020-2025) & (US$ Million)
 Figure 77. Turkey HIV-1 ELISA Kits Revenue (2020-2025) & (US$ Million)
 Figure 78. Egypt HIV-1 ELISA Kits Revenue (2020-2025) & (US$ Million)
 Figure 79. South Africa HIV-1 ELISA Kits Revenue (2020-2025) & (US$ Million)
 Figure 80. HIV-1 ELISA Kits Industry Chain Mapping
 Figure 81. Regional HIV-1 ELISA Kits Manufacturing Base Distribution (%)
 Figure 82. Global HIV-1 ELISA Kits Production Market Share by Region (2020-2031)
 Figure 83. HIV-1 ELISA Kits Production Process
 Figure 84. Regional HIV-1 ELISA Kits Production Cost Structure
 Figure 85. Channels of Distribution (Direct Vs Distribution)
 Figure 86. Bottom-up and Top-down Approaches for This Report
 Figure 87. Data Triangulation
 Figure 88. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Global Infectious Disease Detection ELISA Kits Market Research Report 2024
Global HSV1 ELISA Kits Market Research Report 2024
Global AIDS Test Kits Market Research Report 2024
HIV Test Kits Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global IgM ELISA Kit Market Research Report 2024
Global Immunology Oncology Elisa Kits Market Research Report 2024
Human Anti Herpes Simplex Virus Type 1 ELISA Kit Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global ELISA Kits Market Research Report 2025
Global Chlamydia ELISA Kits Market Research Report 2024
Global CXCR1 ELISA Kit Market Research Report 2024
Global Mycoplasma ELISA Kits Market Research Report 2024
Global AIDS Rapid Testing Kits Market Research Report 2025
Global IL1B ELISA Kit Market Research Report 2024
Global Dengue NS1 ELISA Kits Market Research Report 2024
Global ELISA Test Kits Market Research Report 2024
Global Nuclease ELISA Kit Market Research Report 2024
Global Salmonella ELISA Kits Market Research Report 2024
Global H1N1 ELISA Kits Market Research Report 2024
Global IFN Gamma ELISA Kit Market Research Report 2024
Global Norovirus ELISA Kits Market Research Report 2024

RELATED REPORTS

Global Feline Infectious Peritonitis (FIP) Antivirals Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-4U20267
Mon Nov 24 00:00:00 UTC 2025

Add to Cart

Global Anticoccidial Solutions Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-16R16865
Wed Nov 12 00:00:00 UTC 2025

Add to Cart

Global Bacterial Enteric Disease Testing Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-3F17301
Wed Nov 12 00:00:00 UTC 2025

Add to Cart

Global Whooping Cough Vaccination Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-4B20221
Wed Nov 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions